辛迪制药 SNDX
$9.54 +$0.17 (+1.81%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $9.70 +1.68%
开盘$9.59
昨收$9.37
当日区间$9.22 – $9.78
成交量4.17M
市值$858.87M
市盈率（TTM）–
股息率–
财报
财报日平均波动±6.6%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+21.1%
最差反应-21.6%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 4 Aug 2026 | After Market | ±8.4% | +4.40% | 符合区间 |
| 2026/Q1 | 30 Apr 2026 | After Market | ±12.9% | -10.83% | 符合区间 |
| 2025/Q4 | 26 Feb 2026 | After Market | ±15.4% | +5.03% | 符合区间 |
| 2025/Q3 | 3 Nov 2025 | After Market | ±12.8% | +11.56% | 符合区间 |
| 2025/Q2 | 4 Aug 2025 | After Market | ±14.0% | +21.10% | 超出定价预期 |
| 2025/Q1 | 5 May 2025 | After Market | ±20.3% | -21.59% | 超出定价预期 |
| 2024/Q4 | 3 Mar 2025 | Pre Market | ±17.5% | -1.02% | 符合区间 |
| 2024/Q3 | 5 Nov 2024 | After Market | ±17.3% | +8.43% | 符合区间 |
| 2024/Q2 | 1 Aug 2024 | After Market | ±13.1% | -4.36% | 符合区间 |
| 2024/Q1 | 8 May 2024 | Pre Market | ±9.2% | -3.45% | 符合区间 |
| 2023/Q4 | 27 Feb 2024 | After Market | ±16.4% | -2.17% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | After Market | ±16.4% | +0.14% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±11.2% | -2.90% | 符合区间 |
| 2023/Q1 | 8 May 2023 | After Market | ±9.8% | +6.56% | 符合区间 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±12.0% | -1.93% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | After Market | – | +0.45% | – |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$72.79M+91.8% YoY
营业利润-$40.00M+42.3% YoY
净利润-$49.36M+31.3% YoY
摊薄每股收益-$0.55+33.7% YoY
自由现金流-$30.31M+65.5% YoY
经营现金流-$30.27M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率95.8%
营业利润率-77.0%
净利率-87.5%
净资产收益率-255.9%
资产收益率-34.0%
投入资本回报率-51.1%
流动比率6.77
负债/资产比率97.9%
现金及投资$554.27M
总负债$588.88M
净现金（净负债）-$34.61M
暂无评论——快来第一个聊聊 SNDX。
登录后参与讨论。